AKT1 and cancer: In the present study, we developed a novel detection technique for activated Rac/Cdc42 in human cancer FFPE tissues using a recently developed rapid immunohistochemistry (R-IHC) device, in which the antigen–antibody reaction can be facilitated up to 1,200-fold by alternating current-based high-speed microaggitation14.